We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
Hot Features
Premium
RNS Number:0363Q
Celsis International PLC
24 January 2007
Celsis International plc
Treasury Shares
Celsis International plc (the "Company") announces that on 18 January 2007,
7,000 Ordinary Shares of 5 pence held as Treasury Shares were sold at a price of
220 pence per share.
Following the sale, the Company has 386,500 Treasury Shares. Excluding Treasury
Shares, the Company has 22,483,044 Ordinary Shares of 5 pence each in issue.
Enquiries:
Celsis International plc
Tel: 01638 600 151
Christian Madrolle, Finance Director & Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
END
TRSILFIALVIVFID
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
